The reiteration of an Overweight rating by Cantor Fitzgerald indicates a positive outlook for Prothena Corp. The maintained price target of $129 suggests that the analyst believes the stock has potential for significant upside. This could lead to increased investor interest and potentially a rise in the stock's price in the short term.